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This work group report addresses the central question: What are the critical windows during
development (preconception through puberty) when exposure to xenobiotics may have the greatest
adverse impact on subsequent reproductive health? The reproductive system develops in stages,
with sex-specific organogenesis occurring prenatally and further maturational events occurring in
the perinatal period and at puberty. Complex endocrine signals as well as other regulatory factors
(genetics, growth factors) are involved at all stages. Evidence from animal models and human
studies indicates that many specific events can be perturbed by a variety of toxicants, with
endocrine-mediated mechanisms being the more widely studied. Prioritized research needs include
basic studies on the cellular-molecular and endocrine regulation of sexual differentiation and
development; increased efforts regarding potential adverse effects on development in females,
including breast development; expanded animal studies on different classes of chemicals,
comparing responses during development (prenatal and postnatal) with responses in adults; and,
more extensive explorations regarding the reproductive biology and toxicology of puberty in
humans. Key words: children, fetal, gametes, gonads, reproduction, sexual development, urogenital
system. - Environ Health Perspect 108(suppl 3):505-509 (2000).
http.//ehpnetl.niehs.nih.gov/docs/2000/suppl-3/505-5091emasters/abstract.html
This report summarizes issues discussed by a
work group on reproductive effects on chil-
dren's health. Critical periods during growth
and development were discussed with respect
to the central question: What are the win-
dows of time during development (pre-
conception through pregnancy, childhood,
and puberty) when exposure to xenobiotics
may have the greatest adverse impact on sub-
sequent reproductive health? A background
paper prepared for the work group provided
a review ofkey events in the development of
the reproductive system in humans and test
species and served as a starting point for dis-
cussions concerning critical windows of
exposure with respect to subsequent repro-
ductive health (1). Development is a broad
topic that encompasses the entire life cycle.
Therefore, the work group first agreed that a
working definition of the term critical win-
dow provided in the background paper
would be adopted and used to focus discus-
sion on only those health outcomes that
involve differentiation, development, or
adult functioning ofthe reproductive system.
The definition is repeated here:
Critical windows of development are
limited temporal intervals characterized by
the occurrence ofsets ofdynamic organiza-
tional events that constitute periods during
which exposures may have the greatest
potential to affect later reproductive
competency. (1)
The work group determined that an event
or process would define the window rather
than a specific time period, as the latter varies
greatly in duration among species. The intent
ofthis report is to capture the issues raised in
the discussion and summarize the work
group's recommendations for further
research. Selected examples from the toxicol-
ogy and epidemiology literature are used to
illustrate the points raised, with the recogni-
tion that this report is not intended to be a
comprehensive reviewofthe literature.
Background
Relative to many other species, humans
exhibit a high rate ofinfertility, inadequate
fecundity, and other reproductive disorders.
The extent to which this poor performance
may be related to exposure to environmental
pollution is of great interest to regulatory
agencies. Relevant to thisworkshop is whether
the developing or maturing organism may be
differentially sensitive to reproductive toxi-
cants at critical periods ofdevelopment. It is
difficult to address this question due to the
high background ofinfertility and reproduc-
tive health problems in the U.S. population.
Based on recently released data from the 1995
National Survey ofFamily Growth, approxi-
mately 1 in 10 women in the United States is
infertile (2). While the causes ofinfertility can
be identified in some cases (such as blockage
ofducts that transport gametes as may arise
secondary to medical conditions), others are
poorly understood (such as ovulatory
disorders) or ofentirely unknown etiology (3).
Furthermore, the incidence ofabnormal preg-
nancy outcomes such as preterm deliveries
and low birthweightoffspring is also high and
appears to be increasing. Forexample, the per-
cent ofbabies born preterm, i.e. at less than 37
completed weeks ofgestation, increased from
9.4% in 1981 to 11.0% in 1996, and the per-
cent oflow birth weight infants increased by
10% from 6.7% in 1984 to 7.4% in 1996 (4).
These increases may be related to demo-
graphic factors that influence the risk ofhav-
ing a premature birth or low birth weight
infant, such as attempting pregnancy at an
older age or having multifetal pregnancies
secondary to the use ofovulation-inducing
hormone therapy (3,5,6). However, toxic
substances released into the environment in
recent years may also be a factor. The chal-
lenge is to detect, against this background,
human reproductive risk attributable to
environmental factors encountered during
development.
The complexity ofthe reproductive system
also makes it difficult to identify reproductive
risks possibly due to exposures early in life or
during fetal development. The reproductive
system is immature at birth, with considerable
differentiation occurring during puberty.
While morphologic landmarks ofpuberty
such as Tanner scales in humans and pubertal
indices in rodent test species are useful in
identifying gross effects on sexual develop-
ment (7,8), reproductive function (fertility
and fecundity) cannot be assessed until after
sexual maturation. In humans, this is possible
only for the subset ofindividuals who attempt
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pregnancy. Consequently, adverse reproductive
effects arising from developmental or
childhood exposures may go unnoticed. For
example, ifa gestational exposure resulted in
cervical inadequacy, this effect would not be
detectable until adulthood, and then only if
the woman became pregnant but could not
maintain the pregnancy. Thus, by the time a
reproductive disorder is diagnosed, a lengthy
period oftime may have elapsed, making it
difficult to identify a causative or initiating
agent or pinpoint the critical window(s)
withinwhich the exposure mayhaveoccurred.
In addition to these developmental
considerations, it is also important to recog-
nize that gender-specific differences in repro-
ductive organs and physiology may result in
gender-specific responses to a given toxicant.
In short, one sexmaybe more or less sensitive
to a particular toxicant than the other. All
these factors complicate reproductive hazard
identification and riskassessment.
The background paper (1) identified
important stages ofdevelopment that define
windows ofsusceptibility to reproductive toxi-
cants: the preconception period, the period of
gonadal differentiation, the period ofurogeni-
tal system development, the early postnatal
period, and the peripubertal and pubertal
periods. Discussion ofeach ofthese stages led
to the identification ofa variety of issues
important forchildren's reproductive health.
The Preconceptional Window
The preconceptional window is the period of
time prior to conception when thedeveloping
gametes may be susceptible to genetic or epi-
genetic damage that could affect sexual devel-
opment after fertilization. We know that
damage to spermatozoal DNA can be trans-
mitted to the zygote and may result in a vari-
ety ofdevelopmental problems from early
embryo death to fetal malformations to subtle
changes in gene expression (9). Indeed, the
final stages ofspermiogenesis may be rela-
tively more vulnerable than earlier stages,
since the DNA in condensed spermatids is
incapable ofbeing repaired. Ifdamage occurs
in genes that regulate gonadal determination
or differentiation or the endocrine control of
reproduction (such as hormone receptor
genes), subsequent reproductive potential
could be affected. However, mutagens stud-
ied to date do not appear to act in such a
specific manner.
Likewise, exposures that alter gametic sex
chromosomes can have profound effects on
reproductive development and subsequent
fertility. For example, ifexposures during
meiosis increase the risk of aneuploidy
(wrong number of sex chromosomes) or
structural aberrations ofthe sex chromosomes
(such as translocations or deletions) in either
the oocyte or the spermatozoon, and the
abnormal gametes participate in fertilization,
then the resulting zygote is at riskofabnormal
sexual development. The sex chromosomes
appear to be more susceptible to nondisjunc-
tion than most autosomes (10). Except for
XYY (which can arise from YY disomy in the
spermatozoon and produces a normal sexual
phenotype) and YO (which can arise from X
nullisomy and is incompatible with life),
other numerical errors of the sex chromo-
somes (such as XO, XXY, XXX) result in
abnormal gonadal development and/or
abnormal meiotic disjunction and often
confer infertility in adulthood (10).
Recent development of chromosome-
specific probes has made it possible to iden-
tify aneuploidy and translocations involving
sexchromosomes in sperm, and epidemiology
studies using these methods are being con-
ducted to address the extent to which toxi-
cants may contribute to the risk of sex
chromosome (and autosomal) abnormalities
(11-14). As chromosome-specific probes
become available for rodents (or otherspecies),
this approach can be applied in chemical-
specific toxicology studies (15,16) and
extended to zygotes or preimplantation
embryos to examine exposure-related effects
on either the sperm or the oocyte chromo-
somes (17). Advances in molecular biology
are also making it possible to identify dele-
tions in the Y chromosome that account for
some cases ofhuman infertility (18). The fre-
quency ofY chromosome microdeletions in
azoospermic and severely oligozoospermic
men is estimated to be about 15%, but such
deletions may also occur in infertile men with
apparently normal semen. Many ofthese are
thought to arise de novo, and the extent to
which they maybe induced byenvironmental
contaminants is currently unknown. This
subject is ripe for research.
The Prenatal Windowfor
Reproductive Development
Gonadal Differentation
Early in organogenesis the primordial germ
cells, which arise in the yolk sac, proliferate
and migrate into the genital ridge and form
the indifferent gonad. Ifthis migratoryprocess
were impeded, the ultimate gametogenic
potential ofthe gonad might be affected (19).
The indifferent gonad then develops into an
ovary or testis based on the expression ofspe-
cific genes (1), a process that can be disrupted
by mutations in these genes or alterations in
factors that regulate their expression.
Continued proliferation ofstem cells during
this time is critical for establishing a suitable
primordial germ cell pool ofoogonia or sper-
matogonia. Also, there is evidence that
genomic imprinting may occur in germ cells
during this window, thus determining the
subsequent parental allele-specific expression
ofimprinted genes. Exposure to chemicals that
affect DNA methylation (e.g., 5-azacytidine,
altered methyl status) may disturb this
imprint. There is currentlylittle, ifany, exper-
imental data addressing the possibility that
exposure to toxicants during this critical
windowcan altergonadal differentiation.
Urogenital System Development
Once the gonad has differentiated, it
produces hormonal signals that regulate uro-
genital tract development. Under the direc-
tion oftestosterone and Mijilerian inhibiting
substance (MIS) produced by the fetal testis,
the Wolffian ducts differentiate into the male
reproductive tract organs and the Mullerian
ducts degenerate. In the absence testosterone,
the Miullerian ducts differentiate into the
female reproductive tract and the Wolffian
ducts regress (20). The regulation ofsexual
differentiation is complex. For example, in
the female, coordination ofboth proliferation
and apoptosis is essential to form a patent
female tract. In the male, fusion ofthe uro-
genital sinus is required for penis formation,
and androgenic stimulation is necessary for
descent of the testes through the inguinal
canal and into the scrotum. Exposure to
chemicals with endocrine activity, such as
estrogen mimics, progestins, androgens or
antiandrogens, during the critical period for
development can induce genital malforma-
tions such as hypospadias or testicular mal-
descent in male rodents. Inappropriate
endocrine signals can also masculinize the
external genitalia in female rodents
(19,21-23). Importantly, such effects would
be permanent.
Due in part to the prevalence ofsimilar
effects in wildlife, this topic is currently the
subject ofintense investigation in numerous
laboratories worldwide under the umbrella of
endocrine disruptors research (24). Under
federal mandates, screening tests for chemi-
cals that may act by mimicking hormones
through a variety ofmechanisms are being
developed and validated for use in testing
(25). Numerous workshops have been held
on this topic in recent years, yielding wide-
spread consensus that a) basic research is
needed regarding the hormonal control of
sexual differentiation during development
(and later) and b) better methods and quanti-
tative models are needed to evaluate effects of
compoundswith endocrine activity, especially
after exposures during critical windows of
organogenesis (26,27).
Evidence for homologous effects in
humans is also emerging. The classic example
is the widely studied estrogenic drug diethyl-
stilbestrol (DES). When given to pregnant
women, DES produced a variety ofreproduc-
tive effects in their offspring, most ofwhich
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were not apparent until after puberty [for
example, structural abnormalities of the
cervix, uterus, and fallopian tubes, and
increased risk for adenocarcinoma of the
vagina in daughters (22)]. Inappropriate
exposure to progesterone may also produce
abnormal sexual differentiation. For example,
a recent study reported a 5-fold increase in
hypospadias in the male offspring ofwomen
receiving progesterone subsequent to in vitro
fertilization (IVF) (28). Women who had
IVF received progesterone during early gesta-
tion, which may have contributed to the per-
turbation ofthe fetal endocrine system. It is
also possible that this birth defect in the male
offspring may have been related to other fac-
tors associated with parental subfertility. In a
prospective study of approximately 3,600
male infants in West Germany (29), however,
there was no significant increase in hypospa-
dias for those women havingexposure to prog-
estins via hormonal pregnancy tests. Dosages
and timing ofadministration were consider-
ablydifferent in these two studies, which could
have resulted in these discrepant findings.
Clearly, more human studies are needed to
examine the potential ofhormone mimics in
the environment to alter reproductive tract
development.
BreastDevelopment
The first stage ofbreast development occurs
during organogenesis and involves differentia-
tion ofmammary buds and rudimentary lac-
tiferous ducts in both males and females.
Exposure ofembryo/fetal mammary tissue to
a balanced hormonal environment during
this time may be important with respect to
the number ofestrogen receptors formed and
therefore to the future capability ofthe breast
tissue to respond to estrogen. Thus, this
period is also a critical window for exposures
that alter hormone release or action (1).
The Postnatal to Peripubertal
Windowfor Reproductive
Development
EarlyPostnatal Events
The first six months after birth in the human
and the first three weeks ofpostnatal life in
the rodent is another potential critical win-
dow for testis development. During this time
there is a burst ofSertoli cell proliferation fol-
lowed by its cessation. This phenomenon
establishes the number ofSertoli cells in the
adult testis, which in turn determines the
number ofspermatogonia that can be sup-
ported, and hence the limits ofsperm pro-
duction in the adult. Thyroid hormone is
thought to regulate Sertoli cell proliferation.
In rats, induction ofhypothyroidism in the
perinatal period (during lactation) delays the
cessation of Sertoli cell proliferation. This
results in higher than normal numbers of
Sertoli cells and consequently in significantly
larger testes that produce increased numbers
ofsperm after puberty. The same effect is
observed when rats are exposed to certain
polychlorinated biphenyls (PCBs) during this
period, presumably due to the antithyroid
activity ofPCBs (30Q. Interestingly, these rats
also have enlarged prostates in adulthood.
Recent evidence indicates that altered pro-
lactin levels during early postnatal life or dur-
ing puberty may predispose male rats to
prostatic inflammation (31). Similarly, expo-
sure to the pesticide atrazine during this criti-
cal period alters prolactin levels and induces
prostatic inflammation. These animal studies
raise questions about the relative susceptibil-
ity of humans to such effects and whether
animal models for prostatic inflammation can
be used to predict risks for human prostatic
disease (benign prostatic hyperplasia or
prostate cancer) later in life.
In female rats, inappropriate exposure to
androgens during the neonatal period is also
detrimental. Such exposures at the critical time
give rise to adults with delayed pubertal onset,
decreased regularityofovarian cyclicity, ovaries
with diminished numbers offollicles, and ces-
sation ofovulation atan earlierage (19,21).
Peripuberty(LateChildhood) and
Puberty (Adolescence)
In response to complex hormonal signals at
puberty, the gonads begin to function and
produce gametes. This involves the initiation
ofspermatogenesis from spermatogonia in
the testis and the initiation offolliculogenesis
from primordial follicles in the female.
Recent reviews are available regarding the reg-
ulation ofpuberty in the male and female rat,
and these summarize the rat toxicology litera-
ture regarding known effects ofpharmaceuti-
cals as well as environmental contaminants on
puberty and subsequent reproductive func-
tion (32,33). These reviews propose test pro-
tocols to screen chemicals specifically for
endocrine-disrupting activityduring this criti-
cal window ofdevelopment. However, little
concerted effort has been made to evaluate
the relative sensitivity ofthe gonads during
the period of time when gametogenesis is
becoming established, compared with the
fully functional adult gonad, to chemicals
that target the ovaryor testis specifically.
The hypothalamic-pituitary-gonadal axis
maybe an important target fordisruption, as it
plays critical roles in the establishment ofsper-
matogenesis and ovarian cyclicity during
puberty that carry over into adulthood. As is
well known in humans, individual deviations
from the norm in patterns ofsteroid produc-
tion are associated with low fecundability.
Until recently, however, little was known
about the potential effects of more subtle
changes in hormonal patterns with respect to
conception and implantation (34). Subtle
changes may be more likely to be associated
with effects ofenvironmental exposures (35).
For example, in men, mean concentrations of
luteinizing hormone showed a significant
change during a randomized trial ofinhala-
tion exposures to 50 ppm of toluene (36).
Heavy metals, solvents, and pesticides with
neuroendocrine activity are particularly sus-
pect for their potential to accelerate or delay
puberty. However, little human data are
available on this subject.
In some cases, developing testes may be
more sensitive than adult testes to com-
pounds that target the testis directly (as
opposed to working through the neuroen-
docrine axis). Although data are limited, the
susceptibility appears to depend upon a num-
ber offactors, including the cellular target(s)
and metabolism ofthe toxicant. For example,
immature and pubertal rats appear to be
more sensitive than adults to testicular toxic-
ity induced by exposure to phthalate esters,
an effect that may be related to age-specific
differences in the absorption and/or metabo-
lism ofthese compounds (37-39). Immature
rats are also more sensitive than adults to the
pesticide, 1,2-dibromo-3-chloropropane
(DBCP) (40), and there is limited evidence
that the fetal rat testis may be more sensitive
than the pubertal rat testis (41). DBCP was
banned after reports of infertility in occupa-
tionally exposed men. On the other hand,
immature animals are not always more sus-
ceptible. For example, in the rat fetal Leydig
cells are less sensitive than adult Leydig cells
to a well-known Leydig cell toxicant, ethane
dimethanesulfonate (42). Prepubertal rats are
also relatively insensitive to the testicular toxi-
city of 1,3-dinitrobenzene, a putative Sertoli
cell toxicant, and young adults are less sensi-
tive than older adults (43). In these studies,
in vitro systems for culture ofisolated testicu-
lar cells or seminiferous tubule sections are
proving to be useful for determining the
modes and mechanisms of age-specific
differences in toxicity.
Less is known about age-specific sensitivity
offemales to ovarian toxicants, in part because
relatively few ovarian toxicants have been well
characterized. In animal studies, 4-vinylcyclo-
hexene diepoxide (VCD) destroys oocytes
contained in small preantral follicles. There is
some evidence that adult rats may be less sus-
ceptible to VCD-induced ovotoxicity than
immature rats (44). Depletion ofoocytes has
been associated with early menopause in
women, raising concern about exposures to
ovotoxicchemicals, especiallygiven contempo-
rary secular trends toward delaying childbear-
ing. Earlier menopause is also ofconcern due
tO itS association with other health risks such as
osteoporosis and possibly cardiovascular
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events. In perimenopausal women, smoking
or being exposed to second-hand smoke has
been associated with higher levels offollicle-
stimulating hormones, possibly implying that
exposed individuals may experience earlier
menopause (45). Rodent models are not ideal
for studying these associations, since depletion
ofsmall follides does not necessarily result in
accelerated reproductive senescence in
rodents. Rather, rodents appear to have an
endogenous feedback or compensatory means
ofcensusing the number ofsmall follicles and
adjusting or slowing the rate offuture follicu-
lar atresia. The female primate maybe abetter
model in this regard. Nevertheless, the rodent
studies have shown that complete destruction
ofoocytes in primordial follides appears to be
associated with the development ofovarian
tumors (46).
Another critical window for breast
development (and subsequent susceptibility
to cancer) appears to overlap the prepubertal
and pubertal periods. In rodents, prepubertal
exposure to phytoestrogens was shown to
protect the mammary gland from carcinogen-
induced malignant transformation, possibly
by increasing differentiation ofthe mammary
epithelium (47). On the other hand, exposure
to the phytoestrogen genistein (but not zear-
alenone) during pregnancy increased mam-
mary tumorigenesis in the offspring (48).
Clearly, endocrine-mediated effects are com-
plex and a systematic examination ofthe rela-
tive sensitivity of the prenatal, prepubertal
and pubertal periods is needed.
Comparability of Human and
Laboratory Studies
It is important to understand when animal
models can be representative ofthe human
reproductive exposure-response and when
animal models may be less appropriate.
Similarities between other species and the
human reproductive systems include a) repro-
ductive tissue architecture and regulation of
gametogenesis, b) steroidogenic pathways
(with minor differences), c) specific gene
expression that directs reproductive develop-
ment and function, and d) similarities in the
nature, ifnot the magnitude, ofeffects ofspe-
cific reproductive toxicants. Although the
rodent models are not perfect, rats and mice
are the preferred species for reproductive and
developmental toxicity testing required by
federal guidelines, and there is alarge toxicology
database in rodents that is used for risk assess-
ment. However, limitations with respect tochil-
dren's health studies indude the relatively short
interval (only a few days in absolute terms)
between birth and the initiation ofgametoge-
nesis, as opposed to years in humans. This
short interval in rodents limits interpretation
of studies on chemicals that are thought to
bioaccummulate in children and makes it
difficult to use rodents to address questions of
aggregate or intermittent exposures during
childhood in humans. For such studies, it is
important to explore the suitability ofother
animal models such as rabbits and primates
that have a longer period ofpostnatal devel-
opment before the onset ofpuberty.
Relevant for interspecies extrapolation
with respect to prenatal exposures is the need
to understand differences between placenta-
tion in rodents and humans and the role of
the rodent yolk sac early in pregnancy. These
may result in important species-specific dif-
ferences in xenobiotic availability and metab-
olism. Finally, when examining effects arising
subsequent to prenatal exposures in rodents,
consideration should be given to the inci-
dence of abnormalities both within and
between litters and, in some cases, to the
intrauterine position ofthe fetus.
Concluding Remarks and
Recommendations
Evaluating the impact ofxenobiotics on the
development and adult functioning ofthe
reproductive system in humans poses some
unique challenges. These challenges include
a) the intermittent expression and use ofthe
reproductive organs, b) the potential
extended delays from the time ofinitial expo-
sure to awareness that there may be a prob-
lem such as infertility, and c) the need for the
interaction oftwo individuals before there is
an awareness that a problem exists, e.g., infer-
tility. The use of animal models can over-
come some of these difficulties and inform
human studies with respect to potential
modes and mechanisms oftoxicity.
Based on the work group's discussions of
existing knowledge about reproductive physi-
ologyand about criticalwindows for exposure
to reproductive toxicants, consensus was
reached by the reproductive work group on a
number ofhigh priority goals. This list is
intended to stimulate research to support the
risk assessment process at it pertains to repro-
ductive health ofchildren.
* Determine when an exposure is more
likely to cause an adverse effect, either
qualitative or quantitative, on the develop-
ing offspring compared to the mature
adult.
* Determine the internal regulatory mecha-
nisms that are set early in development
and affect responses later in life.
* Identify the gaps in our understanding of
the differences in reproductive develop-
ment between rodents and humans and
determine the relative importance ofthese
differences for riskassessment.
* Evaluate the sensitivity ofthe primordial
follicles to toxicant exposure. Does sensi-
tivity vary in different physiologic states
(e.g., pre- vs postnatal, or when there are
bursts ofatresia occurring naturally)? In
males, are stem cells more or less sensitive
before or after birth and before or after
puberty?
* Initiate research on female reproduction
beyond adverse pregnancy outcomes. For
example, a) What is the relationship
between external versus internal breast
development? b) What is the relationship
between serum hormones and anovulation?
c) What is the relative sensitivity ofimma-
ture versus mature ovaries to chemicals that
affect folliculogensis?
* Determine when the peripuberty period
begins in humans. How sensitive is the
peripuberty period to xenobiotics? What
organizational events are essential for
moving toward puberty?
* Determine to what extent the period of
late childhood is sensitive to xenobiotics.
For example, peripubertal boys appear to
be just as sensitive as adults to chemo-
therapeutics. More information is needed
to address this question for other classes
oftoxicants.
* In humans, evaluate the relationship of
Tanner scales (external markers ofpuberty)
with internal organ development (e.g.,
appearance ofsperm in ejaculate, matura-
tionofthevasdeferens, serum hormones).
* Use databases such as the National Health
and Nutrition Survey (NHANES) to
compare Tanner stages over time as a
means ofsurveillance for environmental
effects on puberty in humans. NHANES
data might help identify potential child-
hood developmental risks and contribute
to the design and prioritization offuture
studies.
* Generate more information about expo-
sures ofpregnant women and children,
especially to endocrine-active agents,
including environmental contaminants,
drugs, and nutritional supplements, and
the potential consequences of such
exposures.
* Assess the relativevulnerability ofthe male
and female germ cell to toxicants and eval-
uate the consequences on subsequent
generations.
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